Endosomal Toll-like receptors (TLR3 and 9) are overexpressed in bronchoalveolar lavage fluid of patients with lung cancer: Preliminary results

K. Samara, K. Antoniou, E. Vassalou, K. Karagiannis, R. Lymbouridou, N. Siafakas (Heraklion, Greece)

Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Session: Biomarkers in diffuse parenchymal lung disease
Session type: E-Communication Session
Number: 5676
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Samara, K. Antoniou, E. Vassalou, K. Karagiannis, R. Lymbouridou, N. Siafakas (Heraklion, Greece). Endosomal Toll-like receptors (TLR3 and 9) are overexpressed in bronchoalveolar lavage fluid of patients with lung cancer: Preliminary results. Eur Respir J 2010; 36: Suppl. 54, 5676

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Toll-like receptor 4 is overexpressed in bronchoalveolar lavage fluid of patients with fibrotic idiopathic interstitial pneumonias (F-IIPs): preliminary results
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009


The evaluation of soluble Fas and soluble Fas ligand levels of bronchoalveolar lavage (BAL) in lung cancer patients
Source: Eur Respir J 2004; 24: Suppl. 48, 77s
Year: 2004

Triggering receptor expressed on myeloid cells (TREM1): A novel biomarker in the investigation of non-CF bronchiectasis? Preliminary results
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016

Activation of discoidin domain receptor 1 on CD14 positive bronchoalveolar lavage fluid cells induces chemokine production in idiopathic pulmonary fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 675s
Year: 2006

Impaired expression of telomerase activity in bronchoalveolar lavage fluid cells in patients with lung cancer: Preliminary results
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010

CCR5 expression and CC-chemokine levels in broncho-alveolar lavage (BAL) fluid of patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2002; 20: Suppl. 38, 598s
Year: 2002

Inflammasome pathway activation in patients with non-small cell lung cancer (NSCLC): A bronchoalveolar lavage fluid study
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013


Upregulation of neurokinin-1 receptor expression in bronchoalveolar lavage cells and bronchial epithelium of patients with sarcoidosis compared with normal patients
Source: Eur Respir J 2002; 20: Suppl. 38, 226s
Year: 2002

The expression of the chemokine receptors CXCCR3 and CCR4 on T cells reflects the Th2 switch in the bronchoalveolar lavage (BAL) of idiopathic pulmonary fibrosis (IPF) patients
Source: Annual Congress 2004 - Pathobiological and clinical investigations in interstitial lung diseases
Year: 2004


Alveolar lymphocytes (AL) produce interleukin 27 (IL27), antigen presenting cell-secreted cytokine. Increased expression of IL27 in bronchoalveolar lavage (BAL) of pulmonary sarcoidosis (PS) patients
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013

TNF-alpha, IL-1 and IL-6 concentration in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC)
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013

Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases
Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease
Year: 2009


The proinflammatory role of SOCS3 in COPD is regulated by the expression of miRNAs in Bronchoalveolar Lavage (BAL) microvesicles (MV)
Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases
Year: 2021


Surface activation molecules and intracellular cytokines in bronchoalveolar lavage (BAL) and blood CD3+ cells in advanced sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 350s
Year: 2002

Expression of miR-185 targets DNA methyltransferase 1 and Cyclin D2 in IPF and lung cancer in BALF cells: Preliminary results
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015

Upregulation of expression of membrane apoptosis signals by bronchoalveolar lavage cells in patients with pulmonary sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 585s
Year: 2002

Interleukin 27 (IL27) as antitumor tool? Results from bronchoalveolar lavage (BAL) examination
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016

CCR5 expression and CC chemokine levels in idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 25: 701-707
Year: 2005



Cytotoxic phenotype of alveolar lymphocytes (AL) in bronchoalveolar lavage fluid (BALF) from non-small cell lung cancer (NSCLC) patients
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014

Evaluation of IL-10 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC)
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013